Disclosures for "Immunosuppression in Neuromyelitis Optica Spectrum Disorder: A Trial Sequential Analysis and Updated Meta-Analysis"
-
Mr. Menegaz de Almeida has nothing to disclose.
-
Dr. Martinez Lemus has nothing to disclose.
-
Maria Eduarda Souza has nothing to disclose.
-
Francisco de Moraes has nothing to disclose.
-
Mr. Westphal Filho has nothing to disclose.
-
Mr. Lopes has nothing to disclose.
-
Mr. Andrade has nothing to disclose.
-
Miss Rocha Dantas has nothing to disclose.
-
Miss Reis has nothing to disclose.
-
Dr. Reyes has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Reyes has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Reyes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis.